d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A Multicenter, Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations Who Have Progressed on Prior EGFR TKI Treatment [Country] NO [Cancer type] 
Lung cancer
Nordic NECT - Inclusion completed
Cancer type